La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

Pennant Group Crescita futura

Future criteri di controllo 4/6

Si prevede che Pennant Group aumenterà gli utili e i ricavi rispettivamente del 23.6% e 13.3% all'anno, mentre si prevede che l'EPS crescerà del 21.8% all'anno.

Informazioni chiave

23.6%

Tasso di crescita degli utili

21.8%

Tasso di crescita dell'EPS

Healthcare crescita degli utili	19.3%
Tasso di crescita dei ricavi	13.3%
Rendimento futuro del capitale proprio	n/a
Copertura analitica	Low
Ultimo aggiornamento	25 Sep 2024

Aggiornamenti recenti sulla crescita futura

Recent updates

Investors Still Waiting For A Pull Back In The Pennant Group, Inc. (NASDAQ:PNTG)

Sep 14

Investors Could Be Concerned With Pennant Group's (NASDAQ:PNTG) Returns On Capital

Dec 25

Pennant Group (NASDAQ:PNTG) Is Reinvesting At Lower Rates Of Return

Sep 02

Pennant acquires California-based Ardent Hospice and Palliative Care

Aug 16

Pennant Non-GAAP EPS of $0.14 in-line, revenue of $116.3M beats by $4.02M

Aug 08

Pennant Group (NASDAQ:PNTG) Takes On Some Risk With Its Use Of Debt

Jun 28

Is The Pennant Group, Inc. (NASDAQ:PNTG) Trading At A 48% Discount?

May 18

Investors Could Be Concerned With Pennant Group's (NASDAQ:PNTG) Returns On Capital

Apr 29

Is Pennant Group (NASDAQ:PNTG) Using Too Much Debt?

Feb 11

An Intrinsic Calculation For The Pennant Group, Inc. (NASDAQ:PNTG) Suggests It's 50% Undervalued

Jan 21

Previsioni di crescita degli utili e dei ricavi

NasdaqGS:PNTG - Stime future degli analisti e dati finanziari passati (USD Millions )
Data	Ricavi	Guadagni	Flusso di cassa libero	Liquidità dell'operazione	Avg. Numero di analisti
12/31/2026	855	36	35	N/A	2
12/31/2025	760	30	29	N/A	4
12/31/2024	667	24	25	N/A	4
6/30/2024	612	19	8	29	N/A
3/31/2024	575	16	16	25	N/A
12/31/2023	545	13	25	33	N/A
9/30/2023	524	13	14	24	N/A
6/30/2023	502	13	9	20	N/A
3/31/2023	486	7	8	22	N/A
12/31/2022	473	7	-5	9	N/A
9/30/2022	460	1	-5	8	N/A
6/30/2022	454	-3	-13	-2	N/A
3/31/2022	448	3	-23	-15	N/A
12/31/2021	440	3	-25	-18	N/A
9/30/2021	436	9	-20	-16	N/A
6/30/2021	422	12	-9	-5	N/A
3/31/2021	405	14	36	41	N/A
12/31/2020	391	16	43	50	N/A
9/30/2020	372	8	41	50	N/A
6/30/2020	362	5	40	49	N/A
3/31/2020	352	4	4	13	N/A
12/31/2019	339	3	3	10	N/A
9/30/2019	324	10	14	19	N/A
6/30/2019	309	13	12	18	N/A
3/31/2019	296	14	15	19	N/A
12/31/2018	286	16	19	23	N/A
12/31/2017	251	10	N/A	17	N/A
12/31/2016	217	8	N/A	16	N/A

Previsioni di crescita futura degli analisti

Guadagni vs tasso di risparmio: La crescita prevista degli utili di PNTG ( 23.6% all'anno) è superiore al tasso di risparmio ( 2.5% ).

Guadagni vs Mercato: Si prevede che gli utili di PNTG ( 23.6% all'anno) cresceranno più rapidamente del mercato US ( 15.2% all'anno).

Guadagni ad alta crescita: Si prevede che gli utili di PNTG cresceranno in modo significativo nei prossimi 3 anni.

Ricavi vs Mercato: Si prevede che il fatturato di PNTG ( 13.3% all'anno) crescerà più rapidamente del mercato US ( 8.8% all'anno).

Ricavi ad alta crescita: Si prevede che il fatturato di PNTG ( 13.3% all'anno) crescerà più lentamente di 20% all'anno.

Previsioni di crescita dell'utile per azione

Rendimento futuro del capitale proprio

ROE futuro: Dati insufficienti per determinare se il Return on Equity di PNTG è previsto essere elevato tra 3 anni

Pennant Group Crescita futura

Future criteri di controllo 4/6

Informazioni chiave

Aggiornamenti recenti sulla crescita futura

Price target increased by 12% to US$33.50

The Pennant Group, Inc. Updates Earnings Guidance for the Year 2024

Price target increased by 7.8% to US$27.50

Price target increased by 13% to US$24.75

Price target increased by 22% to US$19.50

The Pennant Group, Inc. Provides Revenue Guidance for 2024

Recent updates

Now 21% undervalued

Price target increased by 12% to US$33.50

Investors Still Waiting For A Pull Back In The Pennant Group, Inc. (NASDAQ:PNTG)

Now 21% undervalued

Does Pennant Group (NASDAQ:PNTG) Have A Healthy Balance Sheet?

Second quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

Now 20% undervalued

The Pennant Group, Inc. Updates Earnings Guidance for the Year 2024

CEO & Director notifies of intention to sell stock

The Pennant Group, Inc. to Report Q2, 2024 Results on Aug 06, 2024

Price target increased by 7.8% to US$27.50

Independent Director exercised options to buy US$1.3m worth of stock.

The Pennant Group, Inc. acquired Nurses On Wheels, Inc.

Now 21% undervalued

Here's Why Pennant Group (NASDAQ:PNTG) Can Manage Its Debt Responsibly

Price target increased by 13% to US$24.75

First quarter 2024 earnings: EPS and revenues exceed analyst expectations

The Pennant Group, Inc. (NasdaqGS : PNTG) acquired South Davis Community Hospital, Inc.

The Pennant Group, Inc. to Report Q1, 2024 Results on May 06, 2024

New minor risk - Shareholder dilution

The Pennant Group, Inc., Annual General Meeting, May 23, 2024

President & COO exercised options to buy US$214k worth of stock.

The Pennant Group, Inc. (NASDAQ:PNTG) Not Flying Under The Radar

Price target increased by 22% to US$19.50

Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

The Pennant Group, Inc. Provides Revenue Guidance for 2024

The Pennant Group, Inc. to Report Q4, 2023 Results on Feb 28, 2024

Pennant Group (NASDAQ:PNTG) Takes On Some Risk With Its Use Of Debt

Price target increased by 10% to US$16.00

Third quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

the Pennant Group, Inc. Provides Earnings Guidance for the Year 2023

The Pennant Group, Inc. (NasdaqGS:PNTG) acquired Guardian Hospice of Texas and Guardian Hospice of Oklahoma.

The Pennant Group, Inc. to Report Q3, 2023 Results on Nov 07, 2023

The Pennant Group, Inc. (NasdaqGS:PNTG) acquired Valor HospiceCare.

Price target decreased by 7.1% to US$14.25

Second quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

The Pennant Group, Inc. to Report Q2, 2023 Results on Aug 08, 2023

The Pennant Group, Inc. (NasdaqGS:PNTG) acquired Bluebird Home Health, Bluebird Hospice, and Bluebird Home Care.

Price target decreased by 8.5% to US$15.33

The Pennant Group, Inc. Announces Jennifer Freeman Assume the Role of Senior Vice President of Strategic Partnerships

Investor sentiment deteriorates as stock falls 18%

The Pennant Group, Inc. acquired Assets Of Benefit Health Care.

The Returns On Capital At Pennant Group (NASDAQ:PNTG) Don't Inspire Confidence

First quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Investor sentiment improves as stock rises 16%

Independent Chairman recently bought US$67k worth of stock

Investor sentiment improves as stock rises 20%

Is Pennant Group (NASDAQ:PNTG) A Risky Investment?

Full year 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

The Pennant Group, Inc. to Report Q4, 2022 Results on Feb 23, 2023

Investors Could Be Concerned With Pennant Group's (NASDAQ:PNTG) Returns On Capital

Consensus forecasts updated

The Pennant Group, Inc. (NasdaqGS:PNTG) announces an Equity Buyback for $1 million worth of its shares.

Independent Director recently bought US$203k worth of stock

Consensus forecasts updated

Consensus forecasts updated

The Pennant Group, Inc. Announces Resignation of Derek Bunker,Chief Investment Officer, Executive Vice President and Corporate Secretary, Effective December 31, 2022

Price target decreased to US$15.40

Third quarter 2022 earnings: EPS and revenues exceed analyst expectations

The Pennant Group, Inc. Provides Earnings Guidance for the Year 2022

The Pennant Group, Inc. to Report Q3, 2022 Results on Nov 07, 2022

The Pennant Group, Inc. (NasdaqGS:PNTG) acquired Assets of Kenosha Visiting Nurse Association, Inc.

Price target decreased to US$18.00

Pennant Group (NASDAQ:PNTG) Is Reinvesting At Lower Rates Of Return

The Pennant Group, Inc. (NasdaqGS:PNTG) acquired Assets of Ardent Hospice and Palliative Care.

Pennant acquires California-based Ardent Hospice and Palliative Care

Price target increased to US$18.75

The Pennant Group, Inc. Reaffirms Revenue Guidance for the Full Year 2022

Second quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind